Back
ImmunityBio Quote, Financials, Valuation and Earnings
The AI Energy Miracle
Details Here.
Sell
29
IBRX
ImmunityBio
Last Price:
$2.62
Seasonality Move:
3.53%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.ImmunityBio Price Quote
$2.62
ImmunityBio Key Stats
Sell
29
ImmunityBio (IBRX)
is a Sell
Day range:
$2.61 - $2.71
52-week range:
$2.61 - $10.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
243.64
P/B ratio:
0%
Volume:
7.8M
Avg. volume:
5.8M
1-year change:
-42.16%
Market cap:
$1.8B
Revenue:
$622K
EPS:
$-0.9
How Much Does ImmunityBio Make?
Data Unavailable
Is ImmunityBio Growing As A Company?
Data Unavailable
ImmunityBio Stock Price Performance
-
Did ImmunityBio Stock Go Up Last Month?ImmunityBio share price went down by -46.26% last month
-
Did IBRX's Share Price Rise Over The Last Year?IBRX share price fell by -42.16% over the past 1 year
What Is ImmunityBio 52-Week High & Low?
-
What Is ImmunityBio’s 52-Week High Share Price?ImmunityBio has traded as high as $10.53 over the past 52 weeks
-
What Is ImmunityBio’s 52-Week Low Share Price?ImmunityBio has traded as low as $2.61 over the past 52 weeks
ImmunityBio Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ImmunityBio?
Data Unavailable
Is ImmunityBio Cash Flow Positive?
Data Unavailable
ImmunityBio Return On Invested Capital
Data Unavailable
ImmunityBio Earnings Date & Stock Price
-
What Is ImmunityBio's Stock Price Today?A single share of IBRX can be purchased today for 2.62
-
What Is ImmunityBio’s Stock Symbol?ImmunityBio trades on the nasdaq under the ticker symbol: IBRX
-
When Is ImmunityBio’s Next Earnings Date?The next quarterly earnings date for ImmunityBio is scheduled on May 9, 2025
-
When Is IBRX's next ex-dividend date?ImmunityBio's next ex-dividend date is December 22, 2024
-
How To Buy ImmunityBio Stock?You can buy ImmunityBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ImmunityBio Competitors
-
Who Are ImmunityBio's Competitors?Below is a list of companies who compete with ImmunityBio or are related in some way:
ImmunityBio Dividend Yield
Data Unavailable
ImmunityBio Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 33.33% |
| Revenue: | 7346.34% | 108.75% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 14.25 |
| Upside from Last Price: | 443.89% |
Major Shareholders
Data Unavailable